Novel 1-hydroxypyridin-2-one metal chelators prevent and res-cue ubiquitin proteasomal-related neuronal injury in an in vitro model of Parkinson’s disease

Lewis, Frank W, Fairooz, Safiya, Elson, Joanna L, Hubscher-Bruder, Véronique, Brandel, Jeremy, Soundararajan, Meera, Smith, David, Dexter, David T, Tétard, David and Pienaar, Ilse S (2020) Novel 1-hydroxypyridin-2-one metal chelators prevent and res-cue ubiquitin proteasomal-related neuronal injury in an in vitro model of Parkinson’s disease. Archives of Toxicology. pp. 1-19. ISSN 0340-5761

[img] PDF - Accepted Version
Restricted to SRO admin only

Download (577kB)
[img] PDF - Published Version
Available under License Creative Commons Attribution.

Download (3MB)

Abstract

Ubiquitin proteasome system (UPS) impairment, excessive cellular oxidative stress and iron dyshomeostasis are key to substantia nigra dopaminergic neuronal de-generation in Parkinson's disease (PD); however, a link between these features remains unconfirmed. By using the proteasome inhibitor lactacystin we confirm that nigral injury via UPS impairment disrupts iron homeostasis, in turn increasing oxi-dative stress and promoting protein aggregation. We demonstrate the neuroprotec-tive potential of two novel 1-hydroxy-2(1H)-pyridinone (1,2-HOPO) iron chelators, compounds C6 and C9, against lactacystin-induced cell death. We demonstrate that this cellular preservation relates to the compounds’ iron chelating capabilities and subsequent reduced capacity of iron to form reactive oxygen species (ROS), where we also show that the ligands act as antioxidant agents. Our results also de-monstrate the ability of C6 and C9 to reduce intracellular lactacystin-induced α-synuclein burden. Stability constant measurements confirmed a high affinity of C6 and C9 for Fe3+ and display a 3:1 HOPO:Fe3+ complex formation at physiological pH. Reducing iron reactivity could prevent the demise of nigral dopaminergic neurons. We provide evidence that the lactacystin model presents with several neuropatho-logical hallmarks of PD related to iron dyshomeostasis and that the novel chelating compounds C6 and C9 can protect against lactacystin-related neurotoxicity.

Item Type: Article
Keywords: Alpha-synuclein; Dopaminergic; Iron chelators; Lactacystin; Parkinson’s disease; Reactive oxygen species
Schools and Departments: Brighton and Sussex Medical School > Neuroscience
Depositing User: Ilse Pienaar
Date Deposited: 14 Feb 2020 08:27
Last Modified: 26 Feb 2020 12:30
URI: http://sro.sussex.ac.uk/id/eprint/89904

View download statistics for this item

📧 Request an update
Project NameSussex Project NumberFunderFunder Ref
A Researcher Mobility GrantN.A. (not held at Sussex)The Royal Society of ChemistryUnset